πŸ‡ΊπŸ‡Έ FDA
Patent

US 11911368

Method of treatment of CNS disorders

granted A61KA61K31/00A61K31/4188

Quick answer

US patent 11911368 (Method of treatment of CNS disorders) held by Supernus Pharmaceuticals, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/00, A61K31/4188, A61K9/0053, A61P